chr1_+_207668787
|
2.057
|
NM_001104548
|
LOC642587
|
NPC-A-5
|
chr5_+_177564140
|
1.910
|
|
HNRNPAB
|
heterogeneous nuclear ribonucleoprotein A/B
|
chr5_+_177564139
|
1.672
|
|
HNRNPAB
|
heterogeneous nuclear ribonucleoprotein A/B
|
chr5_+_177564102
|
1.569
|
NM_004499
NM_031266
|
HNRNPAB
|
heterogeneous nuclear ribonucleoprotein A/B
|
chr2_+_232281491
|
1.464
|
|
PTMA
|
prothymosin, alpha
|
chr1_-_204179169
|
1.319
|
NM_052934
NM_134325
|
SLC26A9
|
solute carrier family 26, member 9
|
chr2_+_232281470
|
1.275
|
NM_001099285
NM_002823
|
PTMA
|
prothymosin, alpha
|
chr3_-_48576204
|
1.236
|
NM_033199
|
UCN2
|
urocortin 2
|
chrX_+_77889861
|
1.170
|
NM_005296
|
LPAR4
|
lysophosphatidic acid receptor 4
|
chr21_+_33320080
|
1.134
|
NM_005806
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
chrX_-_24600661
|
1.131
|
NM_001163264
|
PCYT1B
|
phosphate cytidylyltransferase 1, choline, beta
|
chr19_+_40958206
|
1.080
|
NM_001172630
NM_052948
|
ARHGAP33
|
Rho GTPase activating protein 33
|
chr1_+_226404037
|
1.021
|
NM_020435
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
chr16_-_65774904
|
1.019
|
|
KIAA0895L
|
KIAA0895-like
|
chr11_-_16380967
|
1.012
|
NM_001145819
NM_017508
|
SOX6
|
SRY (sex determining region Y)-box 6
|
chr15_+_29406335
|
1.007
|
NM_015995
|
KLF13
|
Kruppel-like factor 13
|
chr11_-_66877519
|
1.006
|
NM_021173
|
POLD4
|
polymerase (DNA-directed), delta 4
|
chr4_-_2233504
|
0.976
|
NM_006454
|
MXD4
|
MAX dimerization protein 4
|
chr19_+_748444
|
0.951
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
chr19_+_748448
|
0.943
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
chr9_+_136358145
|
0.929
|
|
RXRA
|
retinoid X receptor, alpha
|
chr5_+_148186348
|
0.914
|
NM_000024
|
ADRB2
|
adrenergic, beta-2-, receptor, surface
|
chr9_-_132759045
|
0.910
|
NM_198180
|
QRFP
|
pyroglutamylated RFamide peptide
|
chrX_-_10605726
|
0.894
|
NM_001098624
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chrX_+_41078787
|
0.891
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked
|
chr9_+_136358134
|
0.889
|
NM_002957
|
RXRA
|
retinoid X receptor, alpha
|
chr4_-_2233606
|
0.886
|
|
MXD4
|
MAX dimerization protein 4
|
chr15_-_70277163
|
0.863
|
NM_001012642
|
GRAMD2
|
GRAM domain containing 2
|
chr11_+_35154775
|
0.851
|
|
CD44
|
CD44 molecule (Indian blood group)
|
chr13_-_107317460
|
0.830
|
NM_001080396
|
FAM155A
|
family with sequence similarity 155, member A
|
chr14_-_105623358
|
0.807
|
|
IGHA1
IGHD
IGHG1
|
immunoglobulin heavy constant alpha 1
immunoglobulin heavy constant delta
immunoglobulin heavy constant gamma 1 (G1m marker)
|
chr12_-_6535481
|
0.794
|
NM_001039670
NM_001193457
NM_080730
|
IFFO1
|
intermediate filament family orphan 1
|
chr5_+_176807931
|
0.785
|
NM_001174102
|
PRR7
|
proline rich 7 (synaptic)
|
chr10_-_32707549
|
0.773
|
|
EPC1
|
enhancer of polycomb homolog 1 (Drosophila)
|
chr9_+_139255559
|
0.762
|
|
TUBB2C
|
tubulin, beta 2C
|
chr10_+_46413551
|
0.750
|
NM_014696
|
GPRIN2
|
G protein regulated inducer of neurite outgrowth 2
|
chr11_+_113280727
|
0.748
|
NM_006028
|
HTR3B
|
5-hydroxytryptamine (serotonin) receptor 3B
|
chr9_+_139255519
|
0.745
|
NM_006088
|
TUBB2C
|
tubulin, beta 2C
|
chr11_-_20138445
|
0.721
|
NM_001029865
|
DBX1
|
developing brain homeobox 1
|
chr17_-_8054587
|
0.721
|
NM_004217
|
AURKB
|
aurora kinase B
|
chr6_+_50789215
|
0.714
|
NM_172238
|
TFAP2D
|
transcription factor AP-2 delta (activating enhancer binding protein 2 delta)
|
chr6_+_33047952
|
0.712
|
|
BRD2
|
bromodomain containing 2
|
chr9_+_139255563
|
0.710
|
|
TUBB2C
|
tubulin, beta 2C
|
chr1_+_1104939
|
0.707
|
NM_153254
|
TTLL10
|
tubulin tyrosine ligase-like family, member 10
|
chr16_+_580173
|
0.704
|
NM_021168
|
RAB40C
|
RAB40C, member RAS oncogene family
|
chr3_-_46879883
|
0.699
|
NM_000258
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow
|
chr17_-_71648965
|
0.698
|
NM_001454
|
FOXJ1
|
forkhead box J1
|
chr7_+_116447499
|
0.690
|
|
ST7
|
suppression of tumorigenicity 7
|
chr11_+_60448487
|
0.672
|
NM_017870
NM_178031
|
TMEM132A
|
transmembrane protein 132A
|
chr3_+_128190070
|
0.664
|
NM_032242
|
PLXNA1
|
plexin A1
|
chr16_+_580057
|
0.662
|
NM_001172665
NM_001172666
|
RAB40C
|
RAB40C, member RAS oncogene family
|
chr19_+_748452
|
0.662
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
chr19_+_13090101
|
0.659
|
NM_052876
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
chrX_+_41078353
|
0.655
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked
|
chr17_-_1478293
|
0.651
|
|
SLC43A2
|
solute carrier family 43, member 2
|
chr4_+_154345039
|
0.650
|
NM_015271
|
TRIM2
|
tripartite motif containing 2
|
chr21_-_35153664
|
0.648
|
|
RUNX1
|
runt-related transcription factor 1
|
chr1_+_23990228
|
0.648
|
NM_007260
|
LYPLA2
|
lysophospholipase II
|
chr4_+_75529716
|
0.645
|
NM_001657
|
AREG
|
amphiregulin
|
chr1_+_201541269
|
0.643
|
NM_006763
|
BTG2
|
BTG family, member 2
|
chr19_+_1401117
|
0.640
|
NM_005883
|
APC2
|
adenomatosis polyposis coli 2
|
chr16_+_580092
|
0.633
|
|
RAB40C
|
RAB40C, member RAS oncogene family
|
chr1_+_1971762
|
0.607
|
NM_002744
|
PRKCZ
|
protein kinase C, zeta
|
chr22_-_17892859
|
0.606
|
NM_001130861
NM_003277
|
CLDN5
|
claudin 5
|
chr19_+_748390
|
0.606
|
NM_002819
NM_031990
NM_031991
NM_175847
|
PTBP1
|
polypyrimidine tract binding protein 1
|
chr21_+_33364316
|
0.601
|
NM_138983
|
OLIG1
|
oligodendrocyte transcription factor 1
|
chr20_-_61933012
|
0.598
|
|
ZBTB46
|
zinc finger and BTB domain containing 46
|
chr7_+_148613304
|
0.594
|
|
LOC155060
|
AI894139 pseudogene
|
chr1_+_1256585
|
0.583
|
NM_152228
|
TAS1R3
|
taste receptor, type 1, member 3
|
chr17_-_45617899
|
0.576
|
|
COL1A1
|
collagen, type I, alpha 1
|
chr15_-_53822468
|
0.573
|
NM_173814
|
PRTG
|
protogenin
|
chr19_+_60543032
|
0.570
|
NM_032701
|
SUV420H2
|
suppressor of variegation 4-20 homolog 2 (Drosophila)
|
chr19_+_11510578
|
0.570
|
NM_001299
|
CNN1
|
calponin 1, basic, smooth muscle
|
chr17_-_71747867
|
0.568
|
NM_052916
|
RNF157
|
ring finger protein 157
|
chr19_+_59333232
|
0.563
|
NM_014516
|
CNOT3
|
CCR4-NOT transcription complex, subunit 3
|
chr12_-_98072602
|
0.561
|
NM_020140
NM_181670
|
ANKS1B
|
ankyrin repeat and sterile alpha motif domain containing 1B
|
chr7_+_116447527
|
0.561
|
|
ST7
|
suppression of tumorigenicity 7
|
chr1_+_201541241
|
0.560
|
|
BTG2
|
BTG family, member 2
|
chr8_+_1759502
|
0.560
|
NM_014629
|
ARHGEF10
|
Rho guanine nucleotide exchange factor (GEF) 10
|
chr1_+_154855709
|
0.553
|
NM_021817
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2
|
chr22_+_20316968
|
0.553
|
NM_152612
|
CCDC116
|
coiled-coil domain containing 116
|
chr1_+_110683580
|
0.546
|
|
RBM15
|
RNA binding motif protein 15
|
chr7_-_27171673
|
0.539
|
NM_152739
|
HOXA9
|
homeobox A9
|
chr6_+_25862905
|
0.534
|
NM_005495
|
SLC17A4
|
solute carrier family 17 (sodium phosphate), member 4
|
chr17_+_7125702
|
0.531
|
NM_001042
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
chr3_-_187309442
|
0.530
|
NM_004454
|
ETV5
|
ets variant 5
|
chr1_+_203463654
|
0.528
|
NM_014858
|
TMCC2
|
transmembrane and coiled-coil domain family 2
|
chr19_+_1401208
|
0.527
|
|
APC2
|
adenomatosis polyposis coli 2
|
chr19_+_59333287
|
0.523
|
|
CNOT3
|
CCR4-NOT transcription complex, subunit 3
|
chr1_-_50661716
|
0.520
|
NM_032110
|
DMRTA2
|
DMRT-like family A2
|
chr11_+_823007
|
0.520
|
|
CD151
|
CD151 molecule (Raph blood group)
|
chr12_+_6517600
|
0.519
|
|
|
|
chr1_+_32485404
|
0.515
|
NM_032648
|
FAM167B
|
family with sequence similarity 167, member B
|
chr17_+_72376022
|
0.515
|
NM_144677
|
MGAT5B
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B
|
chr6_+_43319199
|
0.514
|
NM_032538
|
TTBK1
|
tau tubulin kinase 1
|
chr4_+_75699652
|
0.509
|
NM_001657
|
AREG
|
amphiregulin
|
chr10_-_134449467
|
0.506
|
NM_177400
|
NKX6-2
|
NK6 homeobox 2
|
chr3_-_12916547
|
0.504
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
chr1_+_148089251
|
0.503
|
NM_001040874
NM_003516
|
HIST2H2AA4
HIST2H2AA3
|
histone cluster 2, H2aa4
histone cluster 2, H2aa3
|
chr19_+_750281
|
0.502
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
chr17_-_77092569
|
0.500
|
|
ACTG1
|
actin, gamma 1
|
chr16_-_65775326
|
0.498
|
NM_001040715
|
KIAA0895L
|
KIAA0895-like
|
chr1_+_110683586
|
0.496
|
|
RBM15
|
RNA binding motif protein 15
|
chrX_+_67965517
|
0.496
|
NM_004429
|
EFNB1
|
ephrin-B1
|
chr13_-_29938029
|
0.495
|
NM_002128
|
HMGB1
|
high-mobility group box 1
|
chr12_+_47658502
|
0.492
|
NM_005430
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
chr1_+_116455898
|
0.491
|
NM_152367
|
MAB21L3
|
mab-21-like 3 (C. elegans)
|
chr21_-_36870736
|
0.489
|
NM_001146077
|
CLDN14
|
claudin 14
|
chr21_+_33364420
|
0.488
|
|
OLIG1
|
oligodendrocyte transcription factor 1
|
chr12_-_94914133
|
0.487
|
NM_002108
|
HAL
|
histidine ammonia-lyase
|
chr3_-_51976428
|
0.486
|
NM_020418
NM_001174100
NM_033008
|
PCBP4
|
poly(rC) binding protein 4
|
chr16_-_11282595
|
0.485
|
NM_002761
|
PRM1
|
protamine 1
|
chr19_-_10352172
|
0.483
|
|
TYK2
|
tyrosine kinase 2
|
chr10_-_13430195
|
0.482
|
NM_001195602
NM_001195604
NM_012247
|
SEPHS1
|
selenophosphate synthetase 1
|
chr11_+_822965
|
0.479
|
|
CD151
|
CD151 molecule (Raph blood group)
|
chr16_-_30274182
|
0.478
|
NM_006110
|
CD2BP2
|
CD2 (cytoplasmic tail) binding protein 2
|
chr1_-_51560469
|
0.477
|
NM_001080494
|
TTC39A
|
tetratricopeptide repeat domain 39A
|
chr17_+_72883759
|
0.475
|
NM_001113494
|
SEPT9
|
septin 9
|
chr17_-_7996409
|
0.472
|
NM_002616
|
PER1
|
period homolog 1 (Drosophila)
|
chr16_-_2201011
|
0.471
|
NM_182563
|
C16orf79
|
chromosome 16 open reading frame 79
|
chr19_+_53819460
|
0.468
|
|
SPHK2
|
sphingosine kinase 2
|
chr15_+_76171981
|
0.465
|
NM_001101404
|
SH2D7
|
SH2 domain containing 7
|
chrX_+_99726445
|
0.465
|
NM_022144
|
TNMD
|
tenomodulin
|
chr17_+_45598363
|
0.460
|
NM_000023
NM_001135697
|
SGCA
|
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
|
chr11_-_71501385
|
0.459
|
NM_014042
|
C11orf51
|
chromosome 11 open reading frame 51
|
chr11_+_18676857
|
0.458
|
|
TMEM86A
|
transmembrane protein 86A
|
chr10_+_73703682
|
0.457
|
NM_019058
|
DDIT4
|
DNA-damage-inducible transcript 4
|
chr17_+_45617676
|
0.457
|
|
|
|
chr1_+_43597185
|
0.454
|
NM_001255
|
CDC20
|
cell division cycle 20 homolog (S. cerevisiae)
|
chr5_+_54434230
|
0.453
|
NM_006144
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
chr1_+_110683467
|
0.452
|
NM_022768
|
RBM15
|
RNA binding motif protein 15
|
chr15_+_72687765
|
0.452
|
NM_003992
|
CLK3
|
CDC-like kinase 3
|
chr1_+_175406685
|
0.451
|
|
FAM5B
|
family with sequence similarity 5, member B
|
chr11_-_780065
|
0.449
|
|
CEND1
|
cell cycle exit and neuronal differentiation 1
|
chr11_+_17697685
|
0.448
|
NM_002478
|
MYOD1
|
myogenic differentiation 1
|
chr5_+_148717762
|
0.448
|
NM_024028
|
PCYOX1L
|
prenylcysteine oxidase 1 like
|
chr15_-_38188333
|
0.446
|
NM_001003940
|
BMF
|
Bcl2 modifying factor
|
chr17_-_39632845
|
0.445
|
|
ATXN7L3
|
ataxin 7-like 3
|
chr1_+_11674365
|
0.445
|
NM_198545
|
C1orf187
|
chromosome 1 open reading frame 187
|
chr16_+_67697622
|
0.444
|
NM_138612
|
HAS3
|
hyaluronan synthase 3
|
chr5_+_170668892
|
0.443
|
NM_021025
|
TLX3
|
T-cell leukemia homeobox 3
|
chr6_-_31890765
|
0.443
|
NM_005527
|
HSPA1L
|
heat shock 70kDa protein 1-like
|
chr11_+_822909
|
0.443
|
NM_001039490
NM_004357
NM_139029
NM_139030
|
CD151
|
CD151 molecule (Raph blood group)
|
chr22_+_17498320
|
0.442
|
NM_053006
|
TSSK2
|
testis-specific serine kinase 2
|
chr2_-_128138435
|
0.441
|
NM_017980
|
LIMS2
|
LIM and senescent cell antigen-like domains 2
|
chr12_+_105501161
|
0.441
|
NM_213594
|
RFX4
|
regulatory factor X, 4 (influences HLA class II expression)
|
chrX_+_41077594
|
0.440
|
NM_001193416
NM_001193417
NM_001356
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked
|
chr7_-_27171648
|
0.440
|
|
HOXA9
|
homeobox A9
|
chr1_-_155095289
|
0.437
|
NM_014215
|
INSRR
|
insulin receptor-related receptor
|
chr6_+_30796064
|
0.436
|
|
TUBB
|
tubulin, beta
|
chr15_+_37660568
|
0.436
|
NM_003246
|
THBS1
|
thrombospondin 1
|
chr17_+_77574476
|
0.431
|
NM_144999
|
LRRC45
|
leucine rich repeat containing 45
|
chr1_-_23543330
|
0.430
|
NM_001102397
NM_001102398
NM_001102399
NM_005826
|
HNRNPR
|
heterogeneous nuclear ribonucleoprotein R
|
chr16_-_30274064
|
0.428
|
|
CD2BP2
|
CD2 (cytoplasmic tail) binding protein 2
|
chr16_-_28425632
|
0.428
|
NM_145659
|
IL27
|
interleukin 27
|
chr1_+_148125090
|
0.426
|
NM_003517
|
HIST2H2AC
|
histone cluster 2, H2ac
|
chr5_-_131854325
|
0.425
|
NM_002198
|
IRF1
|
interferon regulatory factor 1
|
chr13_-_98428244
|
0.424
|
NM_001130048
NM_001130050
|
DOCK9
|
dedicator of cytokinesis 9
|
chr11_-_65813031
|
0.423
|
|
YIF1A
|
Yip1 interacting factor homolog A (S. cerevisiae)
|
chr11_+_18676913
|
0.423
|
NM_153347
|
TMEM86A
|
transmembrane protein 86A
|
chr17_-_59131210
|
0.422
|
NM_030576
|
LIMD2
|
LIM domain containing 2
|
chr1_+_148090804
|
0.420
|
NM_021059
NM_001005464
|
HIST2H3C
HIST2H3A
|
histone cluster 2, H3c
histone cluster 2, H3a
|
chrX_+_106030049
|
0.418
|
NM_001171092
|
CLDN2
|
claudin 2
|
chr22_+_38246509
|
0.414
|
NM_001675
NM_182810
|
ATF4
|
activating transcription factor 4 (tax-responsive enhancer element B67)
|
chr17_+_77528782
|
0.413
|
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1
|
chr1_-_41259973
|
0.412
|
NM_001168247
NM_144990
|
SLFNL1
|
schlafen-like 1
|
chr9_-_138778780
|
0.409
|
NM_203347
|
LCN15
|
lipocalin 15
|
chr19_-_6230927
|
0.408
|
NM_005934
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
chr1_+_154386358
|
0.407
|
NM_001193301
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
|
chr7_+_123036312
|
0.404
|
NM_080928
|
ASB15
|
ankyrin repeat and SOCS box containing 15
|
chr15_-_100280784
|
0.404
|
NM_001004195
|
OR4F4
OR4F17
|
olfactory receptor, family 4, subfamily F, member 4
olfactory receptor, family 4, subfamily F, member 17
|
chr13_-_29937966
|
0.402
|
|
HMGB1
HMGB1P6
|
high-mobility group box 1
high-mobility group box 1 pseudogene 6
|
chr17_-_77573974
|
0.402
|
NM_144998
|
STRA13
|
stimulated by retinoic acid 13 homolog (mouse)
|
chr22_+_36632242
|
0.399
|
NM_033386
|
MICALL1
|
MICAL-like 1
|
chr10_+_114033403
|
0.397
|
NM_058222
|
TECTB
|
tectorin beta
|
chr1_+_196153122
|
0.396
|
NM_020204
|
LHX9
|
LIM homeobox 9
|
chr7_+_134114957
|
0.394
|
|
CALD1
|
caldesmon 1
|
chr9_+_134843918
|
0.393
|
NM_001135031
NM_004188
|
GFI1B
|
growth factor independent 1B transcription repressor
|
chr12_+_105500814
|
0.391
|
|
RFX4
|
regulatory factor X, 4 (influences HLA class II expression)
|
chr19_+_2115119
|
0.390
|
NM_032482
|
DOT1L
|
DOT1-like, histone H3 methyltransferase (S. cerevisiae)
|
chr19_+_47593137
|
0.390
|
|
|
|
chr4_-_41445479
|
0.386
|
|
PHOX2B
|
paired-like homeobox 2b
|
chr9_+_91409746
|
0.385
|
NM_006705
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
chr20_-_538909
|
0.385
|
NM_004609
|
TCF15
|
transcription factor 15 (basic helix-loop-helix)
|
chr3_-_58175437
|
0.384
|
NM_004944
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
chr6_-_110843432
|
0.383
|
NM_003649
NM_004032
|
DDO
|
D-aspartate oxidase
|
chr19_-_3930828
|
0.383
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
chr11_-_63440891
|
0.382
|
NM_173587
|
RCOR2
|
REST corepressor 2
|
chr9_-_139084833
|
0.381
|
NM_178448
|
C9orf140
|
chromosome 9 open reading frame 140
|
chr17_+_7416780
|
0.381
|
NM_001416
|
EIF4A1
|
eukaryotic translation initiation factor 4A1
|
chr12_-_49076658
|
0.381
|
NM_001145475
|
FAM186A
|
family with sequence similarity 186, member A
|
chr11_-_59139755
|
0.380
|
|
OSBP
|
oxysterol binding protein
|
chr17_+_77529070
|
0.376
|
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1
|
chr12_-_67012303
|
0.376
|
NM_017440
NM_020128
|
MDM1
|
Mdm1 nuclear protein homolog (mouse)
|
chr22_-_17512097
|
0.376
|
|
DGCR14
|
DiGeorge syndrome critical region gene 14
|
chr2_-_73151894
|
0.373
|
|
SFXN5
|
sideroflexin 5
|
chr1_-_226679648
|
0.371
|
NM_003493
|
HIST3H3
|
histone cluster 3, H3
|
chr22_-_17512174
|
0.370
|
NM_022719
|
DGCR14
|
DiGeorge syndrome critical region gene 14
|
chr11_+_20577521
|
0.368
|
NM_004211
|
SLC6A5
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 5
|
chr1_-_16033866
|
0.368
|
|
|
|